| Accession |
PRJCA011824 |
| Title |
A Phase I Study of LBL-007 Combined With Toripalimab or LBL-007 Combined With Toripalimab and Axitinib Tablets in the Treatment of Unresectable or Metastatic Melanoma |
| Relevance |
Medical |
| Data types |
Metabolome Data,Biomarker Data,Etc.
|
| Organisms |
Homo sapiens
|
| Description |
(Trial No. LBL-007-CN-002) A Phase I Multi-center Study to Evaluate the Safety ,Tolerability and Efficacy of LBL-007 Combined With Toripalimab or LBL-007 Combined With Toripalimab and Axitinib Tablets in the Treatment of Unresectable or Metastatic Melanoma |
| Sample scope |
Multiisolate |
| Release date |
2022-09-13 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Nanjing Leads Biolabs Co.,Ltd.
|
|
LBL-007-CN-002
|
|
|
|
| Submitter |
Jun
Guo (guoj307@126.com)
|
| Organization |
Beijing Cancer Hospital |
| Submission date |
2022-09-13 |
